Cargando…
Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial
Circulating desmosine is not reduced by treatment with azithromycin in COPD but elevated desmosine may identify a patient group with a greater treatment response http://ow.ly/vN6N30mhBA1
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230815/ https://www.ncbi.nlm.nih.gov/pubmed/30443554 http://dx.doi.org/10.1183/23120541.00136-2018 |
| _version_ | 1783370135730388992 |
|---|---|
| author | Chalmers, James D. Djamin, Remco S. Schouten, Marjolijn Keir, Holly R. Tan, Brendan Aerts, Joachim G.J.V. Huang, Jeffrey T-J. van der Eerden, Menno |
| author_facet | Chalmers, James D. Djamin, Remco S. Schouten, Marjolijn Keir, Holly R. Tan, Brendan Aerts, Joachim G.J.V. Huang, Jeffrey T-J. van der Eerden, Menno |
| author_sort | Chalmers, James D. |
| collection | PubMed |
| description | Circulating desmosine is not reduced by treatment with azithromycin in COPD but elevated desmosine may identify a patient group with a greater treatment response http://ow.ly/vN6N30mhBA1 |
| format | Online Article Text |
| id | pubmed-6230815 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-62308152018-11-15 Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial Chalmers, James D. Djamin, Remco S. Schouten, Marjolijn Keir, Holly R. Tan, Brendan Aerts, Joachim G.J.V. Huang, Jeffrey T-J. van der Eerden, Menno ERJ Open Res Original Research Letter Circulating desmosine is not reduced by treatment with azithromycin in COPD but elevated desmosine may identify a patient group with a greater treatment response http://ow.ly/vN6N30mhBA1 European Respiratory Society 2018-11-12 /pmc/articles/PMC6230815/ /pubmed/30443554 http://dx.doi.org/10.1183/23120541.00136-2018 Text en Copyright ©ERS 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
| spellingShingle | Original Research Letter Chalmers, James D. Djamin, Remco S. Schouten, Marjolijn Keir, Holly R. Tan, Brendan Aerts, Joachim G.J.V. Huang, Jeffrey T-J. van der Eerden, Menno Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial |
| title | Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial |
| title_full | Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial |
| title_fullStr | Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial |
| title_full_unstemmed | Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial |
| title_short | Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial |
| title_sort | circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the columbus randomised controlled trial |
| topic | Original Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230815/ https://www.ncbi.nlm.nih.gov/pubmed/30443554 http://dx.doi.org/10.1183/23120541.00136-2018 |
| work_keys_str_mv | AT chalmersjamesd circulatingdesmosineasabiomarkerofazithromycintreatmentresponseaposthocanalysisofthecolumbusrandomisedcontrolledtrial AT djaminremcos circulatingdesmosineasabiomarkerofazithromycintreatmentresponseaposthocanalysisofthecolumbusrandomisedcontrolledtrial AT schoutenmarjolijn circulatingdesmosineasabiomarkerofazithromycintreatmentresponseaposthocanalysisofthecolumbusrandomisedcontrolledtrial AT keirhollyr circulatingdesmosineasabiomarkerofazithromycintreatmentresponseaposthocanalysisofthecolumbusrandomisedcontrolledtrial AT tanbrendan circulatingdesmosineasabiomarkerofazithromycintreatmentresponseaposthocanalysisofthecolumbusrandomisedcontrolledtrial AT aertsjoachimgjv circulatingdesmosineasabiomarkerofazithromycintreatmentresponseaposthocanalysisofthecolumbusrandomisedcontrolledtrial AT huangjeffreytj circulatingdesmosineasabiomarkerofazithromycintreatmentresponseaposthocanalysisofthecolumbusrandomisedcontrolledtrial AT vandereerdenmenno circulatingdesmosineasabiomarkerofazithromycintreatmentresponseaposthocanalysisofthecolumbusrandomisedcontrolledtrial |